Gallacher Capital Management’s iShares US Medical Devices ETF IHI Stock Holding History

Gallacher Capital Management’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3,979	Closed	-$212K	–	305
2026 Q1	$212K	Hold	3,979	–	–	0.08%	288
2025 Q4	$247K	Sell	3,979 -1,653	-29%	-$102K	0.1%	263
2025 Q3	$338K	Sell	5,632 -227	-4%	-$13.9K	0.13%	217
2025 Q2	$367K	Sell	5,859 -3,360	-36%	-$202K	0.17%	176
2025 Q1	$555K	Buy	9,219 +2	+0%	+$124	0.27%	90
2024 Q4	$538K	Buy	9,217 +8	+0.1%	+$475	0.27%	82
2024 Q3	$545K	Buy	9,209 +5	+0.1%	+$286	0.25%	88
2024 Q2	$516K	Sell	9,204 -428	-4%	-$24K	0.27%	84
2024 Q1	$564K	Buy	9,632 +190	+2%	+$10.7K	0.29%	62
2023 Q4	$510K	Sell	9,442 -3,439	-27%	-$168K	0.28%	66
2023 Q3	$625K	Hold	12,881	–	–	0.39%	41
2023 Q2	$727K	Buy	12,881 +4	+0%	+$220	0.42%	38
2023 Q1	$695K	Sell	12,877 -948	-7%	-$50.5K	0.42%	42
2022 Q4	$727K	Buy	+13,825	New	+$702K	0.44%	40

Other funds holding IHI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Gallacher Capital Management's IHI Position: Q2 2026 in Review

Gallacher Capital Management sold out of iShares US Medical Devices ETF (IHI) in Q2 2026, closing a stake of 3,979 shares — an estimated $212K sold.

Gallacher Capital Management first reported a position in IHI in Q4 2022 and held it in 14 quarters. The position peaked at $727K in Q2 2023. 500 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

Gallacher Capital Management reported no remaining iShares US Medical Devices ETF position as of Q2 2026 after selling out during the quarter.
Gallacher Capital Management sold 3,979 iShares US Medical Devices ETF shares in Q2 2026, an estimated $212K.
Gallacher Capital Management first reported a position in iShares US Medical Devices ETF in Q4 2022 and held it in 14 quarters.
Gallacher Capital Management's iShares US Medical Devices ETF position peaked at $727K in Q2 2023.
500 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on Gallacher Capital Management's 13F filing for Q2 2026, filed 17 Jul 2026.